Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering

The use of multipotent human mesenchymal stem cells (hMSCs) for tissue engineering has been a subject of extensive research. The donor variation in growth, differentiation and in vivo bone forming ability of hMSCs is a bottleneck for standardization of therapeutic protocols. In this study, we isolated and characterized hMSCs from 19 independent donors, aged between 27 and 85 years, and investigated the extent of heterogeneity of the cells and the extent to which hMSCs can be expanded without loosing multipotency. Dexamethasone‐induced ALP expression varied between 1.2‐ and 3.7‐fold, but no correlation was found with age, gender, or source of isolation. The cells from donors with a higher percentage of ALP‐positive cells in control and dexamethasone‐induced groups showed more calcium deposition than cells with lower percentage of ALP positive cells. Despite the variability in osteogenic gene expression among the donors tested, ALP, Collagen type 1, osteocalcin, and S100A4 showed similar trends during the course of osteogenic differentiation. In vitro expansion studies showed that hMSCs can be effectively expanded up to four passages (approximately 10–12 population doublings from a P0 culture) while retaining their multipotency. Our in vivo studies suggest a correlation between in vitro ALP expression and in vivo bone formation. In conclusion, irrespective of age, gender, and source of isolation, cells from all donors showed osteogenic potential. The variability in ALP expression appears to be a result of sampling method and cellular heterogeneity among the donor population. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 25:1029–1041, 2007

[1]  Clemens A van Blitterswijk,et al.  A rapid and efficient method for expansion of human mesenchymal stem cells. , 2007, Tissue engineering.

[2]  C. V. van Blitterswijk,et al.  Inhibition of histone acetylation as a tool in bone tissue engineering. , 2006, Tissue engineering.

[3]  R. Ritchie,et al.  TGF-beta regulates the mechanical properties and composition of bone matrix. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Lepperdinger,et al.  Mesenchymal stem cell aging , 2005, Experimental Gerontology.

[5]  P. Campbell,et al.  Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. , 2005, Stem cells and development.

[6]  Thomas Benjamin,et al.  TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation , 2005, Science.

[7]  M. Hoshino,et al.  Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle Degeneration , 2005, Science.

[8]  Blagoy Blagoev,et al.  Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell Differentiation , 2005, Science.

[9]  S. Goldstein,et al.  Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. , 2005, Bone.

[10]  K. Le Blanc,et al.  Mesenchymal stem cells: progress toward promise. , 2005, Cytotherapy.

[11]  B. Feeley,et al.  Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  J. Li,et al.  Adenoviral‐mediated transfer of human BMP‐6 gene accelerates healing in a rabbit ulnar osteotomy model , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[13]  S. Both,et al.  Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells , 2004, Journal of materials science. Materials in medicine.

[14]  R. F. Morgan,et al.  BMP-9-Transduced Prefabricated Muscular Flaps for the Treatment of Bony Defects , 2004, The Journal of craniofacial surgery.

[15]  Cato T Laurencin,et al.  Bioreactor-based bone tissue engineering: the influence of dynamic flow on osteoblast phenotypic expression and matrix mineralization. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. V. van Blitterswijk,et al.  Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. , 2004, Tissue engineering.

[17]  Christopher H Contag,et al.  Adipose-derived adult stromal cells heal critical-size mouse calvarial defects , 2004, Nature Biotechnology.

[18]  C. V. van Blitterswijk,et al.  Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. , 2004, Bone.

[19]  W. Lattanzi,et al.  Efficient bone formation by gene transfer of human LIM mineralization protein-3 , 2004, Gene Therapy.

[20]  F. Barry,et al.  Mesenchymal stem cells: clinical applications and biological characterization. , 2004, The international journal of biochemistry & cell biology.

[21]  Christopher S. Chen,et al.  Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. , 2004, Developmental cell.

[22]  N. Jørgensen,et al.  Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts , 2004, Steroids.

[23]  Chen Zhongqiang,et al.  Immortalization of human osteoblasts by transferring human telomerase reverse transcriptase gene. , 2004, Biochemical and biophysical research communications.

[24]  M. Blasco,et al.  Telomerase deficiency impairs differentiation of mesenchymal stem cells. , 2004, Experimental cell research.

[25]  Huipin Yuan,et al.  Optimization of bone tissue engineering in goats: a peroperative seeding method using cryopreserved cells and localized bone formation in calcium phosphate scaffolds1 , 2004, Transplantation.

[26]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[27]  H. Tsuda,et al.  Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  Huipin Yuan,et al.  A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats , 2002, Journal of materials science. Materials in medicine.

[29]  Antonios G. Mikos,et al.  Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Jensen,et al.  Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells , 2002, Nature Biotechnology.

[31]  Cun-Yu Wang,et al.  Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression , 2002, Nature Biotechnology.

[32]  Larry L Hench,et al.  Third-Generation Biomedical Materials , 2002, Science.

[33]  K. Tezuka,et al.  Stimulation of Osteoblastic Cell Differentiation by Notch , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[35]  A. Meunier,et al.  Tissue-engineered bone regeneration , 2000, Nature Biotechnology.

[36]  E. Wagner,et al.  Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 , 2000, Nature Medicine.

[37]  M. Pittenger,et al.  Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein Kinase* , 2000, The Journal of Biological Chemistry.

[38]  G. Muschler,et al.  Bone graft materials. An overview of the basic science. , 2000, Clinical orthopaedics and related research.

[39]  S. Harris,et al.  Stimulation of bone formation in vitro and in rodents by statins. , 1999, Science.

[40]  D J Prockop,et al.  Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.

[41]  S. Bruder,et al.  Tissue engineering of bone. Cell based strategies. , 1999, Clinical orthopaedics and related research.

[42]  P. Devane,et al.  Donor site morbidity in the iliac crest bone graft. , 1999, The Australian and New Zealand journal of surgery.

[43]  A. Scutt,et al.  Regulation of Osteogenic Differentiation of Human Bone Marrow Stromal Cells: Interaction Between Transforming Growth Factor-β and 1,25(OH)2 Vitamin D3In Vitro , 1999, Calcified Tissue International.

[44]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[46]  B. Clark,et al.  Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients , 1999, Mechanisms of Ageing and Development.

[47]  K. Kraus,et al.  Mesenchymal stem cells in osteobiology and applied bone regeneration. , 1998, Clinical orthopaedics and related research.

[48]  R. Oreffo,et al.  Skeletal progenitor cells and ageing human populations. , 1998, Clinical science.

[49]  I. Martin,et al.  Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. , 1997, Endocrinology.

[50]  S. Bruder,et al.  Monoclonal antibodies reactive with human osteogenic cell surface antigens. , 1997, Bone.

[51]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[52]  S. Bruder,et al.  Growth kinetics, self‐renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation , 1997, Journal of cellular biochemistry.

[53]  W. B. Upholt,et al.  Regulation of alkaline phosphatase and alpha 2(I) procollagen synthesis during early intramembranous bone formation in the rat mandible. , 1990, Differentiation; research in biological diversity.

[54]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[55]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[56]  B. Clark,et al.  Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts , 2007, Osteoporosis International.

[57]  Ranieri Cancedda,et al.  Bone Marrow Stromal Cells (BMSCs) in Bone Engineering: Limitations and Recent Advances , 2004, Annals of Biomedical Engineering.

[58]  A. Barbero,et al.  Real‐time quantitative RT‐PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro , 2002, Journal of cellular biochemistry.

[59]  A. Caplan,et al.  Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. , 1992, Bone.